210 related articles for article (PubMed ID: 33603167)
61. IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo.
Venkatanarayan A; Raulji P; Norton W; Chakravarti D; Coarfa C; Su X; Sandur SK; Ramirez MS; Lee J; Kingsley CV; Sananikone EF; Rajapakshe K; Naff K; Parker-Thornburg J; Bankson JA; Tsai KY; Gunaratne PH; Flores ER
Nature; 2015 Jan; 517(7536):626-30. PubMed ID: 25409149
[TBL] [Abstract][Full Text] [Related]
62. Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era.
Soussi T; Leroy B; Taschner PE
Hum Mutat; 2014 Jun; 35(6):766-78. PubMed ID: 24729566
[TBL] [Abstract][Full Text] [Related]
63. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
64. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
[TBL] [Abstract][Full Text] [Related]
65. CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma.
Wang H; Song X; Wang Y; Yin X; Liang Y; Zhang T; Xu L; Jiang F; Dong G
Cell Death Dis; 2020 Nov; 11(11):1010. PubMed ID: 33239613
[TBL] [Abstract][Full Text] [Related]
66. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
[TBL] [Abstract][Full Text] [Related]
67. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes.
Sasaki Y; Naishiro Y; Oshima Y; Imai K; Nakamura Y; Tokino T
Oncogene; 2005 Jul; 24(32):5131-6. PubMed ID: 15856012
[TBL] [Abstract][Full Text] [Related]
68. The isoforms of the p53 protein.
Khoury MP; Bourdon JC
Cold Spring Harb Perspect Biol; 2010 Mar; 2(3):a000927. PubMed ID: 20300206
[TBL] [Abstract][Full Text] [Related]
69. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence.
Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC
Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358
[TBL] [Abstract][Full Text] [Related]
70. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
[No Abstract] [Full Text] [Related]
71.
Shirole NH; Pal D; Kastenhuber ER; Senturk S; Boroda J; Pisterzi P; Miller M; Munoz G; Anderluh M; Ladanyi M; Lowe SW; Sordella R
Elife; 2016 Oct; 5():. PubMed ID: 27759562
[No Abstract] [Full Text] [Related]
72. p53 and its isoforms in cancer.
Bourdon JC
Br J Cancer; 2007 Aug; 97(3):277-82. PubMed ID: 17637683
[TBL] [Abstract][Full Text] [Related]
73. Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Donehower LA; Soussi T; Korkut A; Liu Y; Schultz A; Cardenas M; Li X; Babur O; Hsu TK; Lichtarge O; Weinstein JN; Akbani R; Wheeler DA
Cell Rep; 2019 Jul; 28(5):1370-1384.e5. PubMed ID: 31365877
[TBL] [Abstract][Full Text] [Related]
74. RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.
López-Nieva P; Fernández-Navarro P; Vaquero-Lorenzo C; Villa-Morales M; Graña-Castro O; Cobos-Fernández MÁ; López-Lorenzo JL; Llamas P; González-Sanchez L; Sastre I; Pollan M; Malumbres M; Santos J; Fernández-Piqueras J
BMC Cancer; 2018 Apr; 18(1):430. PubMed ID: 29661169
[TBL] [Abstract][Full Text] [Related]
75. Analysis of pig transcriptomes suggests a global regulation mechanism enabling temporary bursts of circular RNAs.
Robic A; Faraut T; Djebali S; Weikard R; Feve K; Maman S; Kuehn C
RNA Biol; 2019 Sep; 16(9):1190-1204. PubMed ID: 31120323
[TBL] [Abstract][Full Text] [Related]
76. The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer.
Napoli M; Flores ER
RNA Biol; 2020 Nov; 17(11):1636-1647. PubMed ID: 31910062
[TBL] [Abstract][Full Text] [Related]
77. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
Hall C; Muller PAJ
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
[TBL] [Abstract][Full Text] [Related]
78. Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma.
Schofield HK; Zeller J; Espinoza C; Halbrook CJ; Del Vecchio A; Magnuson B; Fabo T; Cali Daylan AE; Kovalenko I; Lee HJ; Yan W; Feng Y; Karim SA; Kremer DM; Kumar-Sinha C; Lyssiotis CA; Ljungman M; Morton JP; Galbán S; Fearon ER; Pasca di Magliano M
JCI Insight; 2018 Jan; 3(2):. PubMed ID: 29367463
[TBL] [Abstract][Full Text] [Related]
79. CDK6 Antagonizes p53-Induced Responses during Tumorigenesis.
Bellutti F; Tigan AS; Nebenfuehr S; Dolezal M; Zojer M; Grausenburger R; Hartenberger S; Kollmann S; Doma E; Prchal-Murphy M; Uras IZ; Höllein A; Neuberg DS; Ebert BL; Ringler A; Mueller AC; Loizou JI; Hinds PW; Vogl C; Heller G; Kubicek S; Zuber J; Malumbres M; Farlik M; Villunger A; Kollmann K; Sexl V
Cancer Discov; 2018 Jul; 8(7):884-897. PubMed ID: 29899063
[TBL] [Abstract][Full Text] [Related]
80. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
Crook T; Nicholls JM; Brooks L; O'Nions J; Allday MJ
Oncogene; 2000 Jul; 19(30):3439-44. PubMed ID: 10918601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
